88 drugs, vaccines filling HIV/AIDS pipeline

The FDA has approved more than 30 medicines to treat HIV/AIDS since the disease became widespread in the early 1980s. The life expectancy for many patients with the disease has increased considerably in that time. Without intervention, the average AIDS patient survives 9 to 11 years, and treatment with antiretroviral drugs can extend that to more than 20 years. But more effective medicines are still needed to prevent the spread of the disease. Of the 88 drugs in the HIV/AIDS pipeline (which include therapies in clinical testing or awaiting FDA approval), 49 are antivirals and 27 are vaccines, notes industry group PhRMA in a release. Article

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

With COVID vaccinations expected to start in the coming weeks, 2021 is shaping up to be quite a year for the companies with leading vaccines.

The U.K. became the first Western country to authorize a COVID-19 vaccine, making the Pfizer/BioNTech shot the first mRNA vaccine for widespread use.